Survey on the rising use of Inter Partes Reviews to challenge patents reveals key considerations for originator companies.
Eva Freel
Advertisement
Articles by Eva Freel
Advertisement
Latest Updated Articles
New Challenge to IP InnovationOctober 1st 2016
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Agentic AI and the Future of Commercial Excellence in Life Sciences
3
FDA Expands Approval for Arexvy for Adult Patients Aged 18-49
4
Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals
5